 | This article needs additional citations for verification. (May 2014) |
Nariman Bomanshaw Mehta | |
|---|---|
 Mehta in 2008 | |
| Born | April 20, 1920 |
| Died | August 22, 2014 (aged 94)[1] |
| Nationality | American |
| Alma mater | St. Xavier's College, Mumbai, University of Kansas |
| Known for | Synthesis of antidepressant drug Bupropion (marketed as Wellbutrin) |
| Spouse | Barbara DeShane |
| Children | 2 daughters, 1 son |
| Scientific career | |
| Fields | Organic chemistry |
| Institutions | Seagram, GlaxoSmithKline |
Nariman Bomanshaw Mehta (April 20, 1920 – August 22, 2014)[1] was an Indian-born American organic chemist and pharmacologist who designed, synthesized, and patented the organic compound bupropion, marketed under the name Wellbutrin as an antidepressant and smoking cessation aid.[2]
- ^ a b "Nariman Bomanshaw Mehta: Obituary". Times-News. Burlington, North Carolina. August 23, 2014. Retrieved November 20, 2014.
- ^ U.S. patent 3,819,706